This content is machine translated Pulmonary arterial hypertension (PAH) Results of the Phase III STELLAR study show therapeutic progress In pulmonary arterial hypertension, sotatercept improved primary and secondary endpoints, and thus numerous disease parameters, in a phase 3 study, in addition to standard combination therapy. The molecule targets a…
View Post 12 min This content is machine translated Genetics of pulmonary arterial hypertension. Basics, diagnostics and a new molecular therapeutic approach Pulmonary hypertension (PH) affects approximately 1% of the world’s population. It is associated with a poor prognosis for patients. Various causes condition right ventricular afterload increase, which can lead to… CME-Test
